Cargando…

Monoclonal Antibodies in Dermatooncology—State of the Art and Future Perspectives

Monoclonal antibodies (mAbs) targeting specific proteins are currently the most popular form of immunotherapy used in the treatment of cancer and other non-malignant diseases. Since the first approval of anti-CD20 mAb rituximab in 1997 for the treatment of B-cell malignancies, the market is continuo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bobrowicz, Malgorzata, Zagozdzon, Radoslaw, Domagala, Joanna, Vasconcelos-Berg, Roberta, Guenova, Emmanuella, Winiarska, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826541/ https://www.ncbi.nlm.nih.gov/pubmed/31554169 http://dx.doi.org/10.3390/cancers11101420

Ejemplares similares

Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitors
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

CD37 in B Cell Derived Tumors—More than Just a Docking Point for Monoclonal Antibodies
por: Bobrowicz, Malgorzata, et al.
Publicado: (2020)

Immune Evasion as the Main Challenge for Immunotherapy of Cancer
por: Zagozdzon, Radoslaw, et al.
Publicado: (2022)

Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer
por: Marhelava, Katsiaryna, et al.
Publicado: (2019)

Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
por: Domagala, Antoni, et al.
Publicado: (2018)

Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sézary syndrome
por: Iselin, Christoph, et al.
Publicado: (2021)

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies
por: Winiarska, Magdalena, et al.
Publicado: (2014)

Selection of an optimal promoter for gene transfer in normal B cells
por: Winiarska, Magdalena, et al.
Publicado: (2017)

In Vitro Diffuse Large B-Cell Lymphoma Cell Line Models as Tools to Investigate Novel Immunotherapeutic Strategies
por: Kubacz, Matylda, et al.
Publicado: (2022)

Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives
por: Motta, Giulia, et al.
Publicado: (2010)

Prospects for NK Cell Therapy of Sarcoma
por: Lachota, Mieszko, et al.
Publicado: (2020)

Inhibition of thioredoxin-dependent H(2)O(2) removal sensitizes malignant B-cells to pharmacological ascorbate
por: Graczyk-Jarzynka, Agnieszka, et al.
Publicado: (2018)

Molecular Aspects of Resistance to Immunotherapies—Advances in Understanding and Management of Diffuse Large B-Cell Lymphoma
por: Kusowska, Aleksandra, et al.
Publicado: (2022)

Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma
por: Trzeciecka, Anna, et al.
Publicado: (2015)

Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy
por: Domagala, Antoni, et al.
Publicado: (2018)

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016)

The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
por: Miazek-Zapala, Nina, et al.
Publicado: (2021)

P611: CD37 AS A MOLECULAR TARGET FOR CAR-T CELLS AGAINST CHRONIC LYMPHOCYTIC LEUKEMIA
por: Kusowska, Aleksandra, et al.
Publicado: (2023)

Hybrid techniques for myocardial regeneration: state of the art and future perspectives
por: Kędziora, Anna, et al.
Publicado: (2022)

Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
por: Kardas, Grzegorz, et al.
Publicado: (2022)

Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells
por: Bajor, Malgorzata, et al.
Publicado: (2020)

State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
por: Basile, Debora, et al.
Publicado: (2021)

The Tumor Microenvironment—A Metabolic Obstacle to NK Cells’ Activity
por: Domagala, Joanna, et al.
Publicado: (2020)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

Human(ized) monoclonal antibodies in atopic patients – state of the art
por: YALCIN, ARZU DIDEM, et al.
Publicado: (2020)

Monoclonal Antibodies in Multiple Sclerosis: Present and Future
por: Voge, Natalia V., et al.
Publicado: (2019)

Future of Monoclonal Antibody Therapy in Parkinson’s Disease
por: Kharel, Sanjeev, et al.
Publicado: (2022)

FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy
por: Pyrzynska, Beata, et al.
Publicado: (2018)

Local ablation of pancreatic tumors: State of the art and future perspectives
por: Granata, Vincenza, et al.
Publicado: (2021)

Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
por: Saulite, Ieva, et al.
Publicado: (2020)

The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy
por: Griggs, J, et al.
Publicado: (2009)

Application of Genome Editing Techniques in Immunology
por: Zych, Agata O., et al.
Publicado: (2018)

Monoclonal Antibodies for Chronic Pain Treatment: Present and Future
por: Sánchez-Robles, Eva M., et al.
Publicado: (2021)

Glioblastoma: State of the Art and Future Perspectives
por: Tabatabai, Ghazaleh, et al.
Publicado: (2019)

Neuroenhancement: State of the Art and Future Perspectives
por: Marazziti, Donatella, et al.
Publicado: (2021)

PRDX-1 Supports the Survival and Antitumor Activity of Primary and CAR-Modified NK Cells under Oxidative Stress
por: Klopotowska, Marta, et al.
Publicado: (2022)

Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents
por: Bajor, Malgorzata, et al.
Publicado: (2018)

Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo
por: GABRYSIAK, MAGDALENA, et al.
Publicado: (2016)

Epigenetic Aging and Colorectal Cancer: State of the Art and Perspectives for Future Research
por: Maugeri, Andrea, et al.
Publicado: (2020)

Prospects for Human Monoclonal Antibodies: A Critical Perspective
por: Brown, Nathaniel A.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_91jep9jkgjsjb85cau71n8tv31